참고문헌
- W. Lesslauer, H. Tabuchi, R. Gentz, M. Brockhaus, E. J. Schlaeger, and G. Grau. Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality, Eur. J. Immunol., 21, 2883 (1991). https://doi.org/10.1002/eji.1830211134
- K. M. Mohler, D. S. Torrance, C. A. Smith, R. G. Goodwin, K. E. Stremler, and V. P. Fung, Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists, J. Immunol., 151, 1548 (1993).
- E. A. Hyun, H. J. Lee, W. J. Yoon, S. Y. Park, H. K. Kang, S. J. Kim, and E. S. Yoo, Inhibitory effect of Salvia officinalis on the inflammatory cytokines and inducible nitric oxide synthesis in murine macrophage RAW264.7, Yakhak Hoeji, 48, 159 (2004).
- A. Weisz, L. Cicatiello, and H. Esumi, Regulation of the mouse inducible-type nitric oxide synthase gene promoter by interferon-gamma, bacterial lipopolysaccharide and NG-monomethyl-L-arginine, J. Biochem., 316, 209 (1996). https://doi.org/10.1042/bj3160209
- T. C. Moon, K. C. Chung, K. H. Son, H. P. Kim, S. S. Kang, and H. W. Chang, Screening of cyclooxygenase- 2 inhibitors from natural products, YAKHAK HOEJI, 42, 214 (1998).
- J. L. Masferrer, B. S. Zweifel, P. T. Manning, S. D. Hauser, K. M. Leahy, and W. G. Smith, Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic, Proc. Natl. Acad. Sci. USA, 91, 3228 (1994). https://doi.org/10.1073/pnas.91.8.3228
- K. Seibert, Y. Zhang, K. Leahy, S. Hauser, J. Masferrer, and W. Perkins, Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain, Proc. Natl. Acad. Sci. USA, 91, 12013 (1994). https://doi.org/10.1073/pnas.91.25.12013
- T. Lawrence, D. A. Wiilloughby, and D. W. Gilroy, Anti-inflammatory lipid mediators and insights into the resolution of inflammation, Nat. Rev. Immunol., 2, 787 (2002). https://doi.org/10.1038/nri915
- M. Higuchi, N. Hisgahi, H. Taki, and T. Osawa, Cytolytic mechanisms of activated macrophages. Tumor necrosis factor and L-arginine-dependent mechanisms act synergistically as the major cytolytic mechanisms of activated macrophages, J. Immunol., 144, 1425 (1990).
- N. Laflamme and S. Rivest, Toll-like receptor 4: The missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components, FASEB J., 15, 155 (2001). https://doi.org/10.1096/fj.00-0339com
- V. Willeaume, V. Kruys, T. Mijatovic, and G. Huez, Tumor necrosis factor-alpha production induced by viruses and by lipopolysaccharide in macrophages: similarities and differences, J. Inflamm., 46, 1 (1996).
- L. C. Parish, J. L. Parish, H. B. Routh, and J. A. Witkowski, The treatment of acne vulgaris with low dosage doxycycline, Acta Dermatovenerol. Croat., 13(3), 156 (2005).
- I. Kunihisa, O. Akio, and M. Hajime, Antioxidant activity and inhibitory effect of Gamazumi (Viburnum dilatatum Thunb.) on oxidative damage induced by water immersion restraint stress in rats, International Journal of Food Sciences and Nutrition, 52, 443 (2001). https://doi.org/10.1080/09637480120078339
- M. S. Blois, Antioxidant determinations by the use of a stable free radical, Nature, 29, 1199 (1958).
- T. Mosmann, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, Journal of Immunological Methods, 65, 55 (1983). https://doi.org/10.1016/0022-1759(83)90303-4
- J. H. Ryu, H. Ahn, J. Y. Kim, and Y. K. Kim, Inhibitory activity of plant extracts on nitric oxide synthesis in LPS-activated macrophages, Phytother Res, May, 17(5), 485 (2003). https://doi.org/10.1002/ptr.1180
- H.-Y. Thong and H. I. Maibach, Irritant dermatitis as a model of inflammation, Drug Discovery Today: Disease Mechanisms, 5(2), 221 (2008). https://doi.org/10.1016/j.ddmec.2008.02.002